ImmuLogic Pharmaceutical Corp. (A): March 1991
Below are the available bulk discount rates for each individual item when you purchase a certain amount
Register as a Premium Educator at hbsp.harvard.edu, plan a course, and save your students up to 50% with your academic discount.
Publication Date:
October 22, 1992
Source:
Harvard Business School
Industry:
Pharmaceutical industry
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems of valuation are highlighted. The challenges posed by “windows” for public offerings are considered.
If you’d like to share this PDF, you can purchase copyright permissions by increasing the quantity.
Copyright © 2021 Harvard Business School Publishing. All rights reserved. Harvard Business Publishing is an affiliate of Harvard Business School.
ImmuLogic Pharmaceutical Corp. (A): March 1991
Research & References of ImmuLogic Pharmaceutical Corp. (A): March 1991|A&C Accounting And Tax Services
Source